Recent VRPX Stock Price | VRPX Stock Predictions | |
$2.92 | +584.93% |
$20.00 |
Recent VRPX Analyst Ratings Breakdown, Making VRPX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 1 | 1 | 1 | 1 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the VRPX stock predictions from the analysts covering Virpax Pharmaceuticals Inc, we have collected all of the individual VRPX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 1 different analysts covering VRPX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since VRPX stock predictions may vary widely, another useful metric to consider is the median VRPX stock prediction, which represents the price at which half of the analysts
made VRPX stock predictions that were higher and half made VRPX stock predictions that were lower. This makes for a different take on the VRPX stock predictions out there, as compared to average or mean.
And that median across all the individual VRPX stock predictions was: $20.0 as of 2024-04-26.
The very highest of the VRPX stock predictions for one year price target was $20.0, while the very lowest of the VRPX stock predictions in the analyst group was
$20.0 (with a standard deviation of $0.0). Get the latest Zacks research report on VRPX — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
CHMG Stock Predictions
CELH Stock Predictions
DESP Stock Predictions
BRFS Stock Predictions
AYX Stock Predictions
PRDO Stock Predictions
PAYX Stock Predictions
MVC Stock Predictions
NMRK Stock Predictions
|
|
Strong Buy (4.00 out of 4) 78th percentile
(ranked higher than approx. 78% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |